Dasatinib is safe and effective in unselected chronic myeloid leukaemia elderly patients resistant/intolerant to imatinib-Reference-Cited by-同舟云学术

Dasatinib is safe and effective in unselected chronic myeloid leukaemia elderly patients resistant/intolerant to imatinib

Published:2011-09 Issue:9 Volume:35 Page:1164-1169
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Latagliata Roberto,Breccia Massimo,Castagnetti Fausto,Stagno Fabio,Luciano Luigiana,Gozzini Antonella,Ulisciani Stefano,Cavazzini Francesco,Annunziata Mario,Sorà Federica,Rossi Antonella Russo,Pregno Patrizia,Montefusco Enrico,Abruzzese Elisabetta,Crisà Elena,Musto Pellegrino,Tiribelli Mario,Binotto Gianni,Occhini Ubaldo,Feo Costanzo,Vigneri Paolo,Santini Valeria,Fava Carmen,Rosti Giannantonio,Alimena Giuliana

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference19 articles.

1. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med,2006

2. BCR-ABL Messenger RNA Levels Continue to Decline in Patients with Chronic Phase Chronic Myeloid Leukemia Treated with Imatinib for More Than 5 Years and Approximately Half of All First-Line Treated Patients Have Stable Undetectable BCR-ABL Using Strict Sensitivity Criteria

3. Favorable long-term follow-up results over six years for response, survival and safety with imatinib mesylate therapy in chronic phase chronic myeloid leukemia post failure of interferon-alpha treatment;Hochhaus;Blood,2008

4. Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis;Branford;Blood,2003

5. Strategies for overcoming imatinib resistance in chronic myeloid leukemia;Kujawski;Leuk Lymph,2007

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia;Journal of Clinical Medicine;2024-01-03

2. Treatment after failure of frontline therapy of chronic myeloid leukemia in chronic phase including allogeneic hematopoietic stem cell transplantation;Blood Research;2023-04-30

3. Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials: a real-life cohort observational study;Acta Oncologica;2021-09-09

4. Bosutinib in the real‐life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine‐kinase inhibitors;Hematological Oncology;2021-03-13

5. Second-line Dasatinib Therapy Improved Compliance and Deep Molecular Responses in Imatinib-intolerant Chronic Myeloid Leukemia Patients;Anticancer Research;2020-09